Characteristics | Levels | Low expression of FNDC3B | High expression of FNDC3B | P |
---|---|---|---|---|
n | 89 | 89 | Â | Â |
T stage, n (%) | T1 | 5 (2.8%) | 2 (1.1%) | 0.114 |
T2 | 14 (8%) | 10 (5.7%) | Â | |
T3 | 65 (36.9%) | 77 (43.8%) | Â | |
T4 | 3 (1.7%) | 0 (0%) | Â | |
N stage, n (%) | N0 | 33 (19.1%) | 16 (9.2%) | 0.004 |
N1 | 53 (30.6%) | 71 (41%) | Â | |
M stage, n (%) | M0 | 31 (36.9%) | 49 (58.3%) | 0.980 |
M1 | 1 (1.2%) | 3 (3.6%) | Â | |
Pathologic stage, n (%) | I | 15 (8.6%) | 6 (3.4%) | 0.034 |
II | 68 (38.9%) | 79 (45.1%) | Â | |
III | 3 (1.7%) | 0 (0%) | Â | |
IV | 1 (0.6%) | 3 (1.7%) | Â | |
Radiation therapy, n (%) | No | 58 (35.6%) | 60 (36.8%) | 0.633 |
Yes | 24 (14.7%) | 21 (12.9%) | Â | |
Primary therapy outcome, n (%) | PD | 17 (12.1%) | 33 (23.6%) | 0.079 |
SD | 6 (4.3%) | 3 (2.1%) | Â | |
PR | 4 (2.9%) | 6 (4.3%) | Â | |
CR | 39 (27.9%) | 32 (22.9%) | Â | |
Age, n (%) | ≤ 65 | 38 (21.3%) | 56 (31.5%) | 0.007 |
> 65 | 51 (28.7%) | 33 (18.5%) |  | |
Race, n (%) | Asian | 6 (3.4%) | 5 (2.9%) | 0.972 |
Black or African American | 3 (1.7%) | 3 (1.7%) | Â | |
White | 80 (46%) | 77 (44.3%) | Â | |
Gender, n (%) | Female | 42 (23.6%) | 38 (21.3%) | 0.547 |
Male | 47 (26.4%) | 51 (28.7%) | Â | |
Histologic grade, n (%) | G1 | 24 (13.6%) | 7 (4%) | 0.001 |
G2 | 44 (25%) | 51 (29%) | Â | |
G3 | 17 (9.7%) | 31 (17.6%) | Â | |
G4 | 2 (1.1%) | 0 (0%) | Â | |
Residual tumor, n (%) | R0 | 59 (36%) | 47 (28.7%) | 0.056 |
R1 | 19 (11.6%) | 34 (20.7%) | Â | |
R2 | 3 (1.8%) | 2 (1.2%) | Â | |
Anatomic neoplasm subdivision, n (%) | Head | 67 (37.6%) | 72 (40.4%) | 0.365 |
Other | 22 (12.4%) | 17 (9.6%) | Â | |
Alcohol history, n (%) | No | 29 (17.5%) | 35 (21.1%) | 0.280 |
Yes | 55 (33.1%) | 47 (28.3%) | Â | |
Smoker, n (%) | No | 40 (27.6%) | 26 (17.9%) | 0.133 |
Yes | 38 (26.2%) | 41 (28.3%) | Â | |
History of chronic pancreatitis, n (%) | No | 66 (46.5%) | 63 (44.4%) | 0.854 |
Yes | 7 (4.9%) | 6 (4.2%) | Â | |
History of diabetes, n (%) | No | 56 (38.1%) | 53 (36.1%) | 0.680 |
Yes | 21 (14.3%) | 17 (11.6%) | Â |